Have to add more here mate, for 'doubles' the efficacy when comparing with Keytruda mono, that is the NSCLC case. In head and neck cohort, this type is so much harder and EFTI combo is trippling compare to Keytruda mono, plus the duration of responding (convert to the quality of response) is even greater extent.
Overnight Market report, page-1484
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $282.5K | 960.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 246644 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 409321 | 14 |
View Market Depth
| Last trade - 13.01pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |